-
Signature
-
/s/ Brian Grube, Attorney-in-Fact
-
Stock symbol
-
INTA
-
Transactions as of
-
Jan 19, 2024
-
Transactions value $
-
-$1,415,492
-
Form type
-
4
-
Date filed
-
1/23/2024, 04:40 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
INTA |
Common Stock |
Options Exercise |
$35.6K |
+8.91K |
+1.46% |
$3.99* |
621K |
Jan 19, 2024 |
Direct |
F1 |
| transaction |
INTA |
Common Stock |
Sale |
-$392K |
-8.91K |
-1.44% |
$44.01 |
612K |
Jan 19, 2024 |
Direct |
F1 |
| transaction |
INTA |
Common Stock |
Options Exercise |
$104K |
+26.1K |
+4.26% |
$3.99* |
638K |
Jan 22, 2024 |
Direct |
F1 |
| transaction |
INTA |
Common Stock |
Sale |
-$1.16M |
-26.1K |
-4.09% |
$44.58 |
612K |
Jan 22, 2024 |
Direct |
F1 |
| holding |
INTA |
Common Stock |
|
|
|
|
|
150K |
Jan 19, 2024 |
By Gambatte LLC |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
INTA |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-8.91K |
-2.61% |
$0.00 |
333K |
Jan 19, 2024 |
Common Stock |
8.91K |
$3.99 |
Direct |
F1, F3 |
| transaction |
INTA |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-26.1K |
-7.84% |
$0.00 |
307K |
Jan 22, 2024 |
Common Stock |
26.1K |
$3.99 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: